News

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, ...
An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...
Results of an autopsy-based study revealed that sudden cardiac death and multiorgan pathology may be more closely linked to SSc than previously thought.
Scientists believe they might have found a cure for debilitating autoimmune diseases off the back of a groundbreaking new ...
A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...
A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...
No one knows exactly how the chronic demyelinating disorder multiple sclerosis (MS) ... Additionally, mitochondria instability could be a primitive trigger of MS pathology, ...
The molecular mechanisms underlying myelin sheath destruction in multiple sclerosis lesions remain unresolved. With immunogold–labeled peptides of myelin antigens and high–resolution ...
Webcast of virtual fireside chat today, June 17th, at 7:00 a.m. ETCAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS Neuros ...
US biotech fund BVF Parners has sold its stake in drug developer Syntara, thus exiting all of its ASX life sciences exposures ...
This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.